"The study was first submitted in November 2024, signaling the formal start of the regulatory process for this pediatric program. The most recent update to the record was filed on January 26, 2026, showing that key information on the trial has been reviewed and refreshed. Notably, the trial status is listed as “terminated,” indicating that the study was stopped early and will not reach a planned primary or final completion date; reasons for termination are not detailed in the registry entry."
Friday, January 30, 2026
Larimar’s Pediatric Friedreich’s Ataxia Trial Termination: What Investors Should Know
TipRanks Clinical-Trials-Jan 28, 2026
Subscribe to:
Comments (Atom)
